Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique features of this type of cancer frequently hamper the process of determining clinical presentation and predicting therapy effectiveness. The tumor can spontaneously regress without treatment or actively develop...
Saved in:
| Main Authors: | Irina V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Sergey M. Deyev, Roman V. Kholodenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2018/7394268 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging frontiers in epigenetic-targeted therapeutics for pediatric neuroblastoma
by: Xiaokang Wang, et al.
Published: (2025-07-01) -
Exosomes and immune modulation: implications for neuroblastoma immunotherapy
by: Martina Morini, et al.
Published: (2025-05-01) -
Identification of Contactin-1 as a Potential Biomarker and Therapeutic Target in Neuroblastoma
by: Christa N. Grant, et al.
Published: (2024-11-01) -
Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma
by: Zan Liu, et al.
Published: (2025-02-01) -
Trained autologous cytotoxic T-cells derived from PBMCs or splenocytes for immunotherapy of neuroblastoma
by: Xiaofang Wu, et al.
Published: (2025-06-01)